777 related articles for article (PubMed ID: 10537336)
41. A novel culture environment for generating mature human dentritic cells from peripheral blood CD14+ cells.
Tsiatas ML; Gritzapis AD; Cacoullos NT; Papadhimitriou SI; Baxevanis CN; Papamichail M
Anticancer Res; 2001; 21(2A):1199-206. PubMed ID: 11396164
[TBL] [Abstract][Full Text] [Related]
42. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial.
Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM
J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910
[TBL] [Abstract][Full Text] [Related]
43. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand.
Mach N; Gillessen S; Wilson SB; Sheehan C; Mihm M; Dranoff G
Cancer Res; 2000 Jun; 60(12):3239-46. PubMed ID: 10866317
[TBL] [Abstract][Full Text] [Related]
44. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
Sohn SK; Kim JG; Seo KW; Chae YS; Jung JT; Suh JS; Lee KB
Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046
[TBL] [Abstract][Full Text] [Related]
45. Mobilization of peripheral blood progenitor cells by Betafectin PGG-Glucan alone and in combination with granulocyte colony-stimulating factor.
Patchen ML; Liang J; Vaudrain T; Martin T; Melican D; Zhong S; Stewart M; Quesenberry PJ
Stem Cells; 1998; 16(3):208-17. PubMed ID: 9617896
[TBL] [Abstract][Full Text] [Related]
46. Superior antileukemic activity of murine peripheral blood progenitor cell (PBPC) grafts mobilized by G-CSF and stem cell factor (SCF) as compared to G-CSF alone.
Hartung G; Uharek L; Zeis M; Glass B; Steinmann J; Dreger P; Krönke M; Schmitz N
Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S16-20. PubMed ID: 9712486
[TBL] [Abstract][Full Text] [Related]
47. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
48. Antifungal effects of yeast-derived rhu-GM-CSF in patients receiving high-dose chemotherapy given with or without autologous stem cell transplantation: a retrospective analysis.
Peters BG; Adkins DR; Harrison BR; Velasquez WS; Dunphy FR; Petruska PJ; Bowers CE; Niemeyer R; McIntyre W; Vrahnos D; Auberry SE; Spitzer G
Bone Marrow Transplant; 1996 Jul; 18(1):93-102. PubMed ID: 8832001
[TBL] [Abstract][Full Text] [Related]
49. Cytokine-mobilized peripheral blood progenitor cells.
Nemunaitis J
Semin Oncol; 1996 Apr; 23(2 Suppl 4):9-14. PubMed ID: 8600547
[TBL] [Abstract][Full Text] [Related]
50. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
Vose JM; Bierman PJ; Ruby E; Reed EC; Bishop MR; Tarantolo S; Kessinger A; Armitage JO
Bone Marrow Transplant; 1996 Jun; 17(6):951-6. PubMed ID: 8807099
[TBL] [Abstract][Full Text] [Related]
51. In vitro production of megakaryocytes from PIXY321 versus GM-CSF-mobilized peripheral blood progenitor cells.
Lefebvre P; Winter JN; Rademaker AW; Goolsby C; Cohen I
Stem Cells; 1997; 15(2):112-8. PubMed ID: 9090787
[TBL] [Abstract][Full Text] [Related]
52. Granulocyte colony-stimulating factor (G-CSF) transiently suppresses mitogen-stimulated T-cell proliferative response.
Reyes E; García-Castro I; Esquivel F; Hornedo J; Cortes-Funes H; Solovera J; Alvarez-Mon M
Br J Cancer; 1999 Apr; 80(1-2):229-35. PubMed ID: 10390001
[TBL] [Abstract][Full Text] [Related]
53. [The plasma levels and diagnostic utility of granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage - colony stimulating factor (GM-CSF) in patients with I and II stage of breast cancer].
Ławicki S; Czygier M; Wojtukiewicz M; Szmitkowski M
Przegl Lek; 2009; 66(7):365-9. PubMed ID: 20043577
[TBL] [Abstract][Full Text] [Related]
54. Mobilization of peripheral blood progenitor cells after induction chemotherapy (THP-doxorubicin-vinorelbine-cyclophosphamide-fluorouracil) and granulocyte colony-stimulating factor in breast cancer.
Charrier S; Chassagne J; Curé H; Bay JO; Communal Y; Portefaix G; Ferrière JP; Bétail G; Plagne R; Chollet P
Bone Marrow Transplant; 1998 Nov; 22(9):845-51. PubMed ID: 9827811
[TBL] [Abstract][Full Text] [Related]
55. Generation of dendritic cells ex vivo: differences in steady state versus mobilized blood from patients with breast cancer, with lymphoma, and from normal donors.
Syme RM; Duggan P; Stewart D; Glück S
J Hematother Stem Cell Res; 2001 Oct; 10(5):621-30. PubMed ID: 11672508
[TBL] [Abstract][Full Text] [Related]
56. Comparison of monocyte-dependent T cell inhibitory activity in GM-CSF vs G-CSF mobilized PSC products.
Ageitos AG; Varney ML; Bierman PJ; Vose JM; Warkentin PI; Talmadge JE
Bone Marrow Transplant; 1999 Jan; 23(1):63-9. PubMed ID: 10037052
[TBL] [Abstract][Full Text] [Related]
57. Peripheral blood progenitor cells: a replacement for marrow transplantation?
Champlin RE
Semin Oncol; 1996 Apr; 23(2 Suppl 4):15-21. PubMed ID: 8600543
[TBL] [Abstract][Full Text] [Related]
58. Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation.
Bharadwaj U; Li M; Zhang R; Chen C; Yao Q
Cancer Res; 2007 Jun; 67(11):5479-88. PubMed ID: 17545630
[TBL] [Abstract][Full Text] [Related]
59. Mobilization of dendritic cells and NK cells in non-Hodgkin's lymphoma patients mobilized with different growth factors.
Gazitt Y; Shaughnessy P; Devore P
J Hematother Stem Cell Res; 2001 Feb; 10(1):177-86. PubMed ID: 11276371
[TBL] [Abstract][Full Text] [Related]
60. Lymphokine-activated killer (LAK) cell generation from peripheral blood stem cells by in vitro incubation with low-dose interleukin-2 plus granulocyte-macrophage colony-stimulating factor.
Herrera C; García-Pérez MJ; Ramirez R; Martín C; Alvarez MA; Martinez F; Gómez P; García-Castellano JM; Torres A
Bone Marrow Transplant; 1997 Mar; 19(6):545-51. PubMed ID: 9085733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
